Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_assertion type Assertion NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_head.
- NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_assertion description "[Thus, OBP-401 in combination with docetaxel efficiently enhances the antitumor efficacy both in vitro and in vivo, and the outcome has important implications for tumor-specific oncolytic chemovirotherapies for human cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_provenance.
- NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_assertion evidence source_evidence_literature NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_provenance.
- NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_assertion SIO_000772 16477640 NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_provenance.
- NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_assertion wasDerivedFrom befree-20140225 NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_provenance.
- NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_assertion wasGeneratedBy ECO_0000203 NP695137.RAqdNhDtaVlZgvgT1G-vDR2U5XZTatCDc45grJnf-ODPw130_provenance.